Document Detail

Transcatheter aortic valve implantation for treatment of patients with degenerated aortic bioprostheses--valve-in-valve technique.
MedLine Citation:
PMID:  20824744     Owner:  NLM     Status:  In-Process    
BACKGROUND: The management of patients with degeneration of surgical bioprosthetic valve replacement remains a challenge because of the higher risk of re-do aortic valve replacement. We present a case series of five patients with degenerated aortic bioprostheses treated with transfemoral transcatheter aortic valve implantation (TAVI).
METHODS: From December 2009 to May 2010, five patients with degenerated aortic valve bioprostheses (aortic valve area < 1 cm(2) or severe aortic regurgitation), an excessive operative risk (EuroSCORE ≥ 30%), symptoms of heart failure (NYHA ≥ III) and an internal diameter of bioprosthetic aortic valve 20.5 ± 0.5 mm were included. Procedures were performed without hemodynamic support using femoral arteries. Balloon valvuloplasty with a 20-mm balloon under rapid pacing was carried out before valve implantation. The 26-mm CoreValve prosthesis, 18-F-generation (Medtronic, Minneapolis, Minnesota) was inserted retrograde under fluoroscopic guidance. Invasive and echocardiographic measurements were done immediately before and after TAVI. Clinical followup and echocardiography were performed after procedure (mean followup 72 days ± 60, range: 176-30 days).
RESULTS: In all patients TAVI was successful with immediate decrease of transaortic peak-to-peak pressure (P = 0.002). Mild aortic regurgitation occurred in two patients and one patient received a new permanent pacemaker. Major adverse cardiac and cerebrovascular events did not arise. NYHA functional class improved in all patients and left ventricular ejection fraction increased (P = 0.019).
CONCLUSION: Our experiences with the valve-in-valve technique using the CoreValve prosthesis suggest that transfemoral TAVI is feasible in high risk patients with degenerated aortic bioprostheses.
Michael Gotzmann; Andreas Mügge; Waldemar Bojara
Related Documents :
1572884 - Retrograde delivery of cardioplegia in aortic valve replacement.
15311864 - Hemodynamic characterization of calcified stenotic human aortic valves before and after...
19436814 - Papillary fibroelastoma of the aortic valve as a cause of transient ischemic attack.
12118804 - Morphometric analysis of aortic media in patients with bicuspid and tricuspid aortic va...
12422104 - Arteriovenous graft featuring end-to-end anastomosis to a deep vein for hemodialysis.
24971834 - Simultaneous surgery for obstructive coronary artery disease and ulcerated gastric cancer.
Publication Detail:
Type:  Journal Article     Date:  2010-11-17
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  76     ISSN:  1522-726X     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1000-6     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Wiley-Liss, Inc.
BG-Kliniken Bergmannsheil, Medical Clinic II Cardiology, Ruhr-University Bochum, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Comment In:
Catheter Cardiovasc Interv. 2010 Dec 1;76(7):1007-8   [PMID:  21108376 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Outcomes of vascularized bone graft reconstruction of the mandible in bisphosphonate-related osteone...
Next Document:  Severe coronary disease not amenable to revascularization: Are the series clearly defined?